New medication given every 1-3 months may slash stubborn high cholesterol
While currently available PCSK9 inhibitor medications to lower cholesterol must be administered every few weeks by injection, a new, investigational PCSK9 inhibitor called recaticimab safely lowered bad cholesterol more than 50% when injected every 1-3 months, depending on dose.
Read Original Article: New medication given every 1-3 months may slash stubborn high cholesterol »
